Search Results for: ECSIT

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
Novel CNN1 calponin 1
Novel CORO2B coronin 2B
Novel DYNC1H1 dynein cytoplasmic 1 heavy chain 1
  • Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal
  • MHC class II antigen presentation
  • Separation of Sister Chromatids
  • Resolution of Sister Chromatid Cohesion
  • Regulation of PLK1 Activity at G2/M Transition
  • HSP90 chaperone cycle for steroid hormone receptors (SHR)
  • Loss of Nlp from mitotic centrosomes
  • Recruitment of mitotic centrosome proteins and complexes
  • Loss of proteins required for interphase microtubule organization from the centrosome
  • Recruitment of NuMA to mitotic centrosomes
  • Anchoring of the basal body to the plasma membrane
  • RHO GTPases Activate Formins
  • Neutrophil degranulation
  • COPI-mediated anterograde transport
  • COPI-independent Golgi-to-ER retrograde traffic
  • Mitotic Prometaphase
  • AURKA Activation by TPX2
  • HCMV Early Events
  • Aggrephagy
  • Aggrephagy
  • EML4 and NUDC in mitotic spindle formation
  • Distal hereditary motor neuropathies (dHMN)
Novel MARCHF2 membrane associated ring-CH-type finger 2
Novel MRPL4 mitochondrial ribosomal protein L4
  • Mitochondrial translation initiation
  • Mitochondrial translation elongation
  • Mitochondrial translation elongation
  • Mitochondrial translation termination
Novel NDUFA13 NADH:ubiquinone oxidoreductase subunit A13
  • Respiratory electron transport
  • Complex I biogenesis
  • NADH
Novel SELPLG selectin P ligand
  • Cell surface interactions at the vascular wall
Novel SHFL shiftless antiviral inhibitor of ribosomal frameshifting
A2M alpha-2-macroglobulin
  • Platelet degranulation
  • Intrinsic Pathway of Fibrin Clot Formation
  • Degradation of the extracellular matrix
  • Rho GTPase cycle
  • HDL assembly
  • Becaplermin
  • Cisplatin
  • Bacitracin
  • Zinc
  • Ocriplasmin
  • Silver
  • Zinc acetate
  • Zinc chloride
  • Zinc sulfate, unspecified form
AP1M2 adaptor related protein complex 1 subunit mu 2
  • Nef mediated downregulation of MHC class I complex cell surface expression
  • MHC class II antigen presentation
  • Lysosome Vesicle Biogenesis
  • Golgi Associated Vesicle Biogenesis
APOE apolipoprotein E
  • Nuclear signaling by ERBB4
  • Scavenging by Class A Receptors
  • Scavenging by Class A Receptors
  • Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
  • Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors
  • Post-translational protein phosphorylation
  • Chylomicron assembly
  • Chylomicron remodeling
  • Chylomicron clearance
  • Chylomicron clearance
  • HDL remodeling
  • NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
  • Retinoid metabolism and transport
  • Retinoid metabolism and transport
  • Zinc
  • Copper
  • Zinc acetate
  • Zinc chloride
  • Zinc sulfate, unspecified form
  • Lipoprotein glomerulopathy
  • Hyperlipoproteinemia, type III; Dysbetalipoproteinemia
  • Alzheimer's disease (AD)
APP amyloid beta precursor protein
  • Platelet degranulation
  • ECM proteoglycans
  • Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
  • G alpha (q) signalling events
  • G alpha (i) signalling events
  • Lysosome Vesicle Biogenesis
  • Formyl peptide receptors bind formyl peptides and many other ligands
  • TAK1 activates NFkB by phosphorylation and activation of IKKs complex
  • The NLRP3 inflammasome
  • Advanced glycosylation endproduct receptor signaling
  • Advanced glycosylation endproduct receptor signaling
  • Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models
  • Post-translational protein phosphorylation
  • TRAF6 mediated NF-kB activation
  • Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
  • Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
  • Purinergic signaling in leishmaniasis infection
  • Amyloid fiber formation
  • Deferoxamine
  • Aluminium
  • Zinc
  • L-methionine (R)-S-oxide
  • Resveratrol
  • Tromethamine
  • Phenserine
  • Tetrathiomolybdate
  • CAD106
  • Mito-4509
  • Edonerpic
  • Dimercaprol
  • Copper
  • Florbetaben (18F)
  • Florbetapir (18F)
  • Flutemetamol (18F)
  • Zinc acetate
  • Aluminium phosphate
  • Aluminum acetate
  • Zinc chloride
  • Zinc sulfate, unspecified form
  • Alzheimer's disease (AD)
BFSP2 beaded filament structural protein 2
BLMH bleomycin hydrolase
  • Antigen processing: Ubiquitination & Proteasome degradation
C1orf109 chromosome 1 open reading frame 109
CDC37 cell division cycle 37, HSP90 cochaperone
  • Signaling by ERBB2
  • Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
  • Constitutive Signaling by EGFRvIII
  • Regulation of necroptotic cell death
  • Downregulation of ERBB2 signaling
  • RHOBTB2 GTPase cycle
  • Constitutive Signaling by Overexpressed ERBB2
  • Drug-mediated inhibition of ERBB2 signaling
  • Signaling by ERBB2 KD Mutants
  • Resistance of ERBB2 KD mutants to trastuzumab
  • Resistance of ERBB2 KD mutants to sapitinib
  • Resistance of ERBB2 KD mutants to tesevatinib
  • Resistance of ERBB2 KD mutants to neratinib
  • Resistance of ERBB2 KD mutants to osimertinib
  • Resistance of ERBB2 KD mutants to afatinib
  • Resistance of ERBB2 KD mutants to AEE788
  • Resistance of ERBB2 KD mutants to lapatinib
  • Signaling by ERBB2 ECD mutants
  • Signaling by ERBB2 TMD/JMD mutants
  • Drug resistance in ERBB2 TMD/JMD mutants
CEP55 centrosomal protein 55
CTNNA3 catenin alpha 3
CYP2C18 cytochrome P450 family 2 subfamily C member 18
  • Xenobiotics
  • N,4-Dimethyl-N-(1-phenyl-1H-pyrazol-5-yl)benzenesulfonamide
CYP2C8 cytochrome P450 family 2 subfamily C member 8
  • Xenobiotics
  • CYP2E1 reactions
  • Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)
  • Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)
  • Biosynthesis of maresin-like SPMs
  • Isoniazid
  • Palmitic Acid
  • (5R)-5-(4-{[(2R)-6-HYDROXY-2,5,7,8-TETRAMETHYL-3,4-DIHYDRO-2H-CHROMEN-2-YL]METHOXY}BENZYL)-1,3-THIAZOLIDINE-2,4-DIONE

Page 1 out of 3 pages